{"id":3738,"date":"2026-10-09T14:46:46","date_gmt":"2026-10-09T14:46:46","guid":{"rendered":"https:\/\/nhdbio.com\/?p=3738"},"modified":"2026-10-10T07:26:15","modified_gmt":"2026-10-10T07:26:15","slug":"eloratzp-%e3%82%a2%e3%83%9f%e3%83%aa%e3%83%b3-%e3%83%81%e3%83%ab%e3%82%bc%e3%83%91%e3%83%81%e3%83%89-%e3%83%95%e3%82%a7%e3%83%bc%e3%82%ba2b-%e7%b5%90%e6%9e%9c%e3%81%ae%e8%a7%a3%e8%aa%ac","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/ja\/eloratzp-amylin-tirzepatide-phase2b-results-explained\/","title":{"rendered":"EloraTZP\uff1a\u7814\u7a76\u8005\u304c\u30a2\u30df\u30ea\u30f3\u3068\u30c1\u30eb\u30bc\u30d1\u30c1\u30c9\u3092\u7d44\u307f\u5408\u308f\u305b\u308b\u7406\u7531"},"content":{"rendered":"<p>\u7814\u7a76\u8005\u304c\u30a4\u30f3\u30af\u30ec\u30c1\u30f3\u6cbb\u7642\u306b\u5225\u306e\u6e80\u8179\u611f\u95a2\u9023\u30b7\u30b0\u30ca\u30eb\u3092\u8ffd\u52a0\u3059\u308b\u3068\u3069\u3046\u306a\u308b\u3067\u3057\u3087\u3046\u304b\uff1fEloraTZP\u306f\u305d\u306e\u554f\u3044\u306b\u7b54\u3048\u3088\u3046\u3068\u3059\u308b\u4e00\u3064\u306e\u8a66\u307f\u3067\u3059\u3002\u521d\u671f\u7d50\u679c\u306f\u5fc3\u5f37\u3044\u3082\u306e\u3067\u3059\u304c\u3001\u5fcd\u5bb9\u6027\u306b\u95a2\u3059\u308b\u77e5\u898b\u306b\u3082\u540c\u69d8\u306b\u6ce8\u76ee\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<h2>\u4f55\u304c\u691c\u8a3c\u3055\u308c\u307e\u3057\u305f\u304b\uff1f<\/h2>\n<p>\u30ea\u30ea\u30fc\u793e\u306f30\u5e742026\u6708367\u65e5\u306b\u3001\u904e\u4f53\u91cd\u307e\u305f\u306f\u80a5\u6e80\u304b\u30642\u578b\u7cd6\u5c3f\u75c5\u306e\u6210\u4eba\u3092\u5bfe\u8c61\u3068\u3057\u305f\u7b2c2b\u76f8\u8a66\u9a13\u306e\u7d50\u679c\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002EloraTZP\u306f\u3001\u9078\u629e\u7684\u30a2\u30df\u30ea\u30f3\u53d7\u5bb9\u4f53\u4f5c\u52d5\u85ac\u3067\u3042\u308b\u30a8\u30ed\u30e9\u30ea\u30f3\u30c1\u30c9\u3068\u3001GIP\/GLP-1\u53d7\u5bb9\u4f53\u4e8c\u91cd\u4f5c\u52d5\u85ac\u3067\u3042\u308b\u30c1\u30eb\u30bc\u30d1\u30c1\u30c9\u3092\u7d44\u307f\u5408\u308f\u305b\u305f\u3082\u306e\u3067\u3059\u3002\u8a66\u9a13\u671f\u9593\u306f48\u9031\u9593\u3067\u3057\u305f\u3002<\/p>\n<table>\n<thead>\n<tr>\n<th>\u5831\u544a\u3055\u308c\u305f\u7fa4<\/th>\n<th>\u5e73\u5747\u4f53\u91cd\u6e1b\u5c11\u3001\u6709\u52b9\u6027\u63a8\u5b9a\u5024<\/th>\n<th>HbA1c\u4f4e\u4e0b<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>\u5831\u544a\u3055\u308c\u305f\u4e2d\u3067\u6700\u3082\u9ad8\u3044EloraTZP\u4f75\u7528<\/td>\n<td>23.3%<\/td>\n<td>2.9\u30d1\u30fc\u30bb\u30f3\u30c8\u30dd\u30a4\u30f3\u30c8<\/td>\n<\/tr>\n<tr>\n<td>\u30c1\u30eb\u30bc\u30d1\u30c1\u30c915 mg<\/td>\n<td>14.8%<\/td>\n<td>2.4\u30d1\u30fc\u30bb\u30f3\u30c8\u30dd\u30a4\u30f3\u30c8<\/td>\n<\/tr>\n<tr>\n<td>\u30d7\u30e9\u30bb\u30dc<\/td>\n<td>3.0%<\/td>\n<td>0.3 \u30d1\u30fc\u30bb\u30f3\u30c8\u30dd\u30a4\u30f3\u30c8<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>\u4e3b\u306a\u6bd4\u8f03\u306f\u4f75\u7528\u5bfe\u30d7\u30e9\u30bb\u30dc\u3067\u3042\u308a\u3001\u4ed6\u306e\u6bd4\u8f03\u306f\u526f\u6b21\u7684\u3067\u3042\u3063\u305f\u3002\u6709\u5bb3\u4e8b\u8c61\u306b\u3088\u308b\u4f75\u7528\u7fa4\u306e\u4e2d\u6b62\u7387\u306f10.8%\u304b\u308927.0%\u306e\u7bc4\u56f2\u3067\u3042\u308a\u3001\u30c1\u30eb\u30bc\u30d1\u30c1\u30c9\u3067\u306f2.9%\u3067\u3042\u3063\u305f\u3002\u80c3\u8178\u95a2\u9023\u4e8b\u8c61\u306f\u4f75\u7528\u7fa4\u3067\u3088\u308a\u983b\u7e41\u306b\u307f\u3089\u308c\u305f\u3002<\/p>\n<p>\u53c2\u52a0\u8005\u306f2\u3064\u306e\u6210\u5206\u3092\u5225\u3005\u306b\u53d7\u3051\u53d6\u308a\u307e\u3057\u305f\u3002\u5171\u914d\u5408\u88fd\u5264\u306e\u7b2c3\u76f8\u88fd\u54c1\u304c\u8a08\u753b\u3055\u308c\u3066\u3044\u307e\u3057\u305f\u304c\u3001\u3053\u306e\u7b2c2b\u76f8\u8a66\u9a13\u3067\u306f\u691c\u8a3c\u3055\u308c\u3066\u3044\u307e\u305b\u3093\u3002\u3053\u306e\u4f75\u7528\u306f\u4f9d\u7136\u3068\u3057\u3066\u6cbb\u9a13\u6bb5\u968e\u306b\u3042\u308a\u307e\u3057\u305f\u3002<\/p>\n<h2>\u306a\u305c\u30a2\u30df\u30ea\u30f3\u30b7\u30b0\u30ca\u30eb\u3092\u8ffd\u52a0\u3059\u308b\u306e\u304b\uff1f<\/h2>\n<p>The research question is whether engaging another appetite-related pathway adds a useful effect. \u201cMore pathways\u201d should not be treated as a guarantee of a better overall outcome. An additional mechanism can bring additional questions about tolerability, formulation and how an effect changes over time.<\/p>\n<p>\u3053\u306e\u8a71\u984c\u306b\u521d\u3081\u3066\u89e6\u308c\u308b\u8aad\u8005\u306b\u3068\u3063\u3066\u91cd\u8981\u306a\u533a\u5225\u306f\u3001\u6210\u5206\u540d\u3068\u305d\u306e\u7d44\u307f\u5408\u308f\u305b\u81ea\u4f53\u306e\u9055\u3044\u3067\u3059\u3002\u4e8c\u3064\u306e\u6210\u5206\u3092\u4e00\u7dd2\u306b\u8abf\u3079\u305f\u7814\u7a76\u306f\u3001\u81ea\u52d5\u7684\u306b\u3069\u3061\u3089\u304b\u4e00\u65b9\u306e\u6210\u5206\u3060\u3051\u306e\u8a3c\u62e0\u306b\u306a\u308b\u308f\u3051\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/p>\n<h2>\u6709\u76ca\u6027\u3068\u5fcd\u5bb9\u6027\u3092\u4f75\u305b\u3066\u8aad\u3080<\/h2>\n<p>\u5831\u544a\u3055\u308c\u305f\u6700\u5927\u306e\u4f53\u91cd\u6e1b\u5c11\u306f\u3001\u7279\u5b9a\u306e\u89e3\u6790\u306b\u304a\u3051\u308b\u7fa4\u5e73\u5747\u3067\u3042\u308b\u3002\u305d\u308c\u306f\u3059\u3079\u3066\u306e\u53c2\u52a0\u8005\u304c\u9054\u6210\u3057\u305f\u7d50\u679c\u3067\u306f\u306a\u304f\u3001\u65b0\u305f\u306a\u4eba\u306b\u5bfe\u3059\u308b\u4e88\u6e2c\u3067\u3082\u306a\u3044\u3002<\/p>\n<p>\u4e2d\u6b62\u7387\u306e\u6570\u5b57\u3082\u91cd\u8981\u3067\u3059\u3002\u6cbb\u7642\u3092\u7d99\u7d9a\u3067\u304d\u305f\u4eba\u3060\u3051\u3092\u898b\u3066\u3082\u3001\u7814\u7a76\u3092\u5341\u5206\u306b\u7406\u89e3\u3059\u308b\u3053\u3068\u306f\u3067\u304d\u307e\u305b\u3093\u3002\u89e3\u6790\u304c\u4e2d\u6b62\u3057\u305f\u53c2\u52a0\u8005\u3092\u3069\u306e\u3088\u3046\u306b\u6271\u3063\u3066\u3044\u308b\u304b\u3001\u5225\u306e\u6cbb\u7642\u52b9\u679c\u306e\u554f\u3044\u306e\u3082\u3068\u3067\u3082\u7d50\u679c\u304c\u540c\u69d8\u306b\u4fdd\u305f\u308c\u308b\u304b\u3092\u78ba\u8a8d\u3057\u307e\u3057\u3087\u3046\u3002<\/p>\n<p>\u3053\u306e\u767a\u8868\u3067\u306f\u4f75\u7528\u7fa4\u5168\u4f53\u306b\u308f\u305f\u308b\u7bc4\u56f2\u304c\u793a\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u305d\u306e\u7bc4\u56f2\u3092\u3001\u7fa4\u5225\u306e\u5831\u544a\u306a\u3057\u306b\u6700\u3082\u826f\u597d\u306a\u6210\u7e3e\u306e\u7fa4\u306b\u3059\u3079\u3066\u5272\u308a\u5f53\u3066\u308b\u3079\u304d\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/p>\n<h2>\u5225\u3005\u306e\u6ce8\u5c04\u306f\u5b8c\u6210\u3057\u305f\u914d\u5408\u88fd\u5264\u3067\u306f\u3042\u308a\u307e\u305b\u3093<\/h2>\n<p>\u30e9\u30d9\u30eb\u306b2\u3064\u306e\u540d\u79f0\u3092\u8a18\u8f09\u3057\u3066\u3082\u3001\u305d\u306e\u88fd\u5264\u304c\u8a66\u9a13\u4ecb\u5165\u3068\u4e00\u81f4\u3059\u308b\u3053\u3068\u3092\u793a\u3059\u3082\u306e\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002\u540c\u4e00\u6027\u3001\u6bd4\u7387\u3001\u88fd\u5264\u3001\u304a\u3088\u3073\u9001\u9054\u30b7\u30b9\u30c6\u30e0\u306f\u5225\u3005\u306e\u8ab2\u984c\u3067\u3059\u3002\u5c06\u6765\u306e\u5171\u914d\u5408\u88fd\u5264\u306b\u306f\u72ec\u81ea\u306e\u958b\u767a\u3068\u30a8\u30d3\u30c7\u30f3\u30b9\u304c\u5fc5\u8981\u3067\u3059\u3002<\/p>\n<p>\u3053\u308c\u306f\u307e\u305f\u3001\u30ab\u30bf\u30ed\u30b0\u4e0a\u306e\u6df7\u5408\u7269\u304c\u8a66\u9a13\u306e\u6210\u7e3e\u6570\u5024\u3092\u6d41\u7528\u3059\u3079\u304d\u3067\u306a\u3044\u7406\u7531\u3067\u3082\u3042\u308a\u307e\u3059\u3002\u6210\u5206\u540d\u3092\u5171\u6709\u3057\u3066\u3044\u3066\u3082\u3001\u4e92\u63db\u6027\u304c\u78ba\u7acb\u3055\u308c\u308b\u308f\u3051\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/p>\n<h2>\u4f55\u304c\u8a3c\u62e0\u3092\u5f37\u3081\u308b\u3067\u3057\u3087\u3046\u304b\uff1f<\/h2>\n<p>\u8a73\u7d30\u306a\u5831\u544a\u3067\u306f\u3001\u5404\u7fa4\u306e\u6210\u7e3e\u3068\u6709\u5bb3\u4e8b\u8c61\u3001\u63a8\u5b9a\u5024\u306e\u4e0d\u78ba\u5b9f\u6027\u3001\u6b20\u6e2c\u30c7\u30fc\u30bf\u306e\u6271\u3044\u3001\u304a\u3088\u3073\u8a08\u753b\u3055\u308c\u305f\u7d71\u8a08\u6bd4\u8f03\u3092\u793a\u3059\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002\u305d\u306e\u5f8c\u3001\u5f8c\u671f\u6bb5\u968e\u306e\u8a66\u9a13\u3067\u3001\u521d\u671f\u306e\u30b7\u30b0\u30ca\u30eb\u304c\u3088\u308a\u5927\u898f\u6a21\u3067\u5b9a\u7fa9\u3055\u308c\u305f\u8a2d\u5b9a\u3067\u3082\u7dad\u6301\u3055\u308c\u308b\u304b\u3092\u691c\u8a3c\u3067\u304d\u307e\u3059\u3002<\/p>\n<p>\u305d\u308c\u307e\u3067\u306f\u3001\u3053\u308c\u306f\u8ffd\u8de1\u3059\u3079\u304d\u7814\u7a76\u958b\u767a\u3067\u3042\u308a\u3001\u7814\u7a76\u5ba4\u306e\u30d6\u30ec\u30f3\u30c9\u304c\u540c\u3058\u81e8\u5e8a\u7d50\u679c\u3092\u3082\u305f\u3089\u3059\u3068\u4e3b\u5f35\u3059\u308b\u6839\u62e0\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/p>\n<h2>\u5b9e\u9a8c\u5ba4\u7814\u7a76\u7528\u306e\u95a2\u9023\u8cc7\u6599<\/h2>\n<p>\u53c2\u7167 <a href=\"https:\/\/nhdbio.com\/ja\/%e8%a3%bd%e5%93%81\/%e3%83%86%e3%82%a3%e3%83%ab%e3%82%bc%e3%83%91%e3%83%81%e3%83%89\/\">\u30c6\u30a3\u30eb\u30bc\u30d1\u30c1\u30c9<\/a> \u95a2\u9023\u3059\u308b\u7814\u7a76\u5ba4\u30ab\u30bf\u30ed\u30b0\u30d5\u30a1\u30df\u30ea\u30fc\u306b\u3064\u3044\u3066\u306f\u3002 <a href=\"https:\/\/nhdbio.com\/ja\/%e8%a3%bd%e5%93%81\/%e3%82%ab%e3%82%b0%e3%83%aa%e3%83%aa%e3%83%b3%e3%83%81%e3%83%89\/\">\u30ab\u30b0\u30ea\u30ea\u30f3\u30c1\u30c9<\/a> \u306f\u5225\u306e\u30a2\u30df\u30ea\u30f3\u95a2\u9023\u7814\u7a76\u6750\u6599\u3067\u3042\u308a\u3001\u30a8\u30ed\u30e9\u30ea\u30f3\u30c1\u30c9\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002\u3053\u308c\u3089\u306e\u30ea\u30f3\u30af\u306f\u3001NHD \u304c EloraTZP \u307e\u305f\u306f\u8a66\u9a13\u76f8\u5f53\u306e\u914d\u5408\u3092\u4f9b\u7d66\u3059\u308b\u3053\u3068\u3092\u793a\u3059\u3082\u306e\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/p>\n<p>\u304a\u554f\u3044\u5408\u308f\u305b\u306e\u969b\u306f\u3001\u7269\u8cea\u540d\u3001\u6570\u91cf\u3001\u4e88\u5b9a\u3055\u308c\u3066\u3044\u308b\u5b9e\u9a8c\u5ba4\u691c\u67fb\u3092\u304a\u77e5\u3089\u305b\u304f\u3060\u3055\u3044\u3002\u9078\u629e\u3057\u305f\u30d0\u30ea\u30a2\u30f3\u30c8\u306b\u3064\u3044\u3066\u5229\u7528\u53ef\u80fd\u306a\u540c\u4e00\u6027\u3001\u7d14\u5ea6\u3001\u305d\u306e\u4ed6\u306e\u5206\u6790\u8a18\u9332\u3092\u304a\u5c0b\u306d\u304f\u3060\u3055\u3044\u3002 <a href=\"https:\/\/nhdbio.com\/ja\/%e5%bc%95%e7%94%a8\/\">NHD \u306b\u88fd\u54c1\u60c5\u5831\u3092\u30ea\u30af\u30a8\u30b9\u30c8\u3059\u308b<\/a>.<\/p>\n<p>\u3053\u308c\u3089\u306e\u8a66\u9a13\u3067\u4f7f\u7528\u3055\u308c\u305f\u533b\u85ac\u54c1\u306f\u3001NHD \u306e\u30ab\u30bf\u30ed\u30b0\u6750\u6599\u3068\u4e92\u63db\u6027\u306f\u3042\u308a\u307e\u305b\u3093\u3002\u8a66\u9a13\u7d50\u679c\u306f\u3001\u81e8\u5e8a\u52b9\u679c\u3001\u88fd\u5264\u306e\u540c\u7b49\u6027\u3001\u307e\u305f\u306f NHD \u30d0\u30c3\u30c1\u306e\u54c1\u8cea\u3092\u78ba\u7acb\u3059\u308b\u3082\u306e\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/p>\n<h2>\u7d9a\u304d\u3092\u8aad\u3080<\/h2>\n<p><a href=\"https:\/\/nhdbio.com\/ja\/%e3%82%ab%e3%82%b0%e3%83%aa%e3%83%aa%e3%83%b3%e3%83%81%e3%83%89%e5%af%be%e3%82%ab%e3%82%b0%e3%83%aa%e3%82%bb%e3%83%9e%e3%81%ae%e3%82%a8%e3%83%93%e3%83%87%e3%83%b3%e3%82%b9%e3%81%ae%e9%99%90%e7%95%8c\/\">\u95a2\u9023\u3059\u308b\u7814\u7a76\u89e3\u8aac\u3092\u898b\u308b<\/a>.<\/p>\n<h2>\u51fa\u5178\u304a\u3088\u3073\u7de8\u96c6\u30ec\u30d3\u30e5\u30fc<\/h2>\n<p><a href=\"https:\/\/lilly.gcs-web.com\/news-releases\/news-release-details\/lillys-eloratzp-combination-eloralintide-and-tirzepatide\">\u30ea\u30ea\u30fc\u7b2c2b\u76f8\u767a\u8868\u300130\u5e742026\u6708<\/a>. \u30a2\u30af\u30bb\u30b9\u65e5\uff1a9\u5e7410\u67082026\u65e5\u3002\u3053\u306e\u8a18\u4e8b\u306f\u4f01\u696d\u767a\u8868\u3092\u8aac\u660e\u3059\u308b\u3082\u306e\u3067\u3042\u308a\u3001\u72ec\u7acb\u3057\u305f\u67fb\u8aad\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002AI\u652f\u63f4\u306b\u3088\u308b\u51fa\u5178\u304a\u3088\u3073\u8aad\u307f\u3084\u3059\u3055\u306e\u78ba\u8a8d\u306f\u516c\u958b\u524d\u306b\u5b8c\u4e86\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>NHD \u306e\u30ab\u30bf\u30ed\u30b0\u6750\u6599\u306f\u3001\u5b9f\u9a13\u5ba4\u3067\u306e\u7814\u7a76\u3001\u958b\u767a\u304a\u3088\u3073\u88fd\u9020\u7528\u3067\u3042\u308a\u3001\u30d2\u30c8\u307e\u305f\u306f\u52d5\u7269\u3067\u306e\u4f7f\u7528\u3092\u76ee\u7684\u3068\u3057\u3066\u3044\u307e\u305b\u3093\u3002\u672c\u8a18\u4e8b\u306f\u6cbb\u7642\u3084\u6295\u4e0e\u306e\u6307\u793a\u3092\u63d0\u4f9b\u3059\u308b\u3082\u306e\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/p>","protected":false},"excerpt":{"rendered":"<p>\u30ea\u30ea\u30fc\u793e\u306f\u30012\u578b\u7cd6\u5c3f\u75c5\u306e367\u6210\u4eba\u3092\u5bfe\u8c61\u3068\u3057\u305f48\u9031\u9593\u306e\u7b2c2b\u76f8\u4f75\u7528\u8a66\u9a13\u3092\u5831\u544a\u3057\u307e\u3057\u305f\u3002\u4f53\u91cd\u306e\u7d50\u679c\u3001\u4e2d\u6b62\u4f8b\u3001\u88fd\u5264\u4e0a\u306e\u9650\u754c\u306b\u3064\u3044\u3066\u7406\u89e3\u3057\u307e\u3057\u3087\u3046\u3002<\/p>","protected":false},"author":1,"featured_media":3923,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"370,320","pim_article_type":"Research news explained","pim_evidence_level":"Company-reported results; study-specific limitations retained","pim_reviewer":"Codex AI editorial","pim_reviewed_date":"2026-10-09","pim_editorial_note":"AI-assisted source and readability checks, not independent peer review.","pim_review_status":"reviewed","pim_review_reason":"Primary sources and corrections checked; study populations and limitations retained; product-family links and enquiry paths reviewed; plain-language edit completed.","pim_creation_method":"AI-assisted writing","pim_sources":"[]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-3738","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>EloraTZP: Why Researchers Are Combining Amylin and Tirzepatide<\/title>\n<meta name=\"description\" content=\"Lilly reported a 48-week phase 2b combination study in 367 adults with type 2 diabetes. Understand the weight results, discontinuations and formulation limits.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/ja\/eloratzp-\u30a2\u30df\u30ea\u30f3-\u30c1\u30eb\u30bc\u30d1\u30c1\u30c9-\u30d5\u30a7\u30fc\u30ba2b-\u7d50\u679c\u306e\u89e3\u8aac\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EloraTZP: Why Researchers Are Combining Amylin and Tirzepatide\" \/>\n<meta property=\"og:description\" content=\"Lilly reported a 48-week phase 2b combination study in 367 adults with type 2 diabetes. Understand the weight results, discontinuations and formulation limits.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/ja\/eloratzp-\u30a2\u30df\u30ea\u30f3-\u30c1\u30eb\u30bc\u30d1\u30c1\u30c9-\u30d5\u30a7\u30fc\u30ba2b-\u7d50\u679c\u306e\u89e3\u8aac\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-09T14:46:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-10T07:26:15+00:00\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/eloratzp-amylin-tirzepatide-phase2b-results-explained\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/eloratzp-amylin-tirzepatide-phase2b-results-explained\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"EloraTZP: Why Researchers Are Combining Amylin and Tirzepatide\",\"datePublished\":\"2026-10-09T14:46:46+00:00\",\"dateModified\":\"2026-10-10T07:26:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/eloratzp-amylin-tirzepatide-phase2b-results-explained\\\/\"},\"wordCount\":625,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/eloratzp-amylin-tirzepatide-phase2b-results-explained\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/nhd-comic-3738.jpg\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/eloratzp-amylin-tirzepatide-phase2b-results-explained\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/eloratzp-amylin-tirzepatide-phase2b-results-explained\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/eloratzp-amylin-tirzepatide-phase2b-results-explained\\\/\",\"name\":\"EloraTZP: Why Researchers Are Combining Amylin and Tirzepatide\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/eloratzp-amylin-tirzepatide-phase2b-results-explained\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/eloratzp-amylin-tirzepatide-phase2b-results-explained\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/nhd-comic-3738.jpg\",\"datePublished\":\"2026-10-09T14:46:46+00:00\",\"dateModified\":\"2026-10-10T07:26:15+00:00\",\"description\":\"Lilly reported a 48-week phase 2b combination study in 367 adults with type 2 diabetes. Understand the weight results, discontinuations and formulation limits.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/eloratzp-amylin-tirzepatide-phase2b-results-explained\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/eloratzp-amylin-tirzepatide-phase2b-results-explained\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/eloratzp-amylin-tirzepatide-phase2b-results-explained\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/nhd-comic-3738.jpg\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/nhd-comic-3738.jpg\",\"width\":1536,\"height\":1024,\"caption\":\"Editorial comic illustration: Amylin Meets Tirzepatide. Conceptual cover, not experimental imagery.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/eloratzp-amylin-tirzepatide-phase2b-results-explained\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EloraTZP: Why Researchers Are Combining Amylin and Tirzepatide\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/ja\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"EloraTZP\uff1a\u7814\u7a76\u8005\u304c\u30a2\u30df\u30ea\u30f3\u3068\u30c1\u30eb\u30bc\u30d1\u30c1\u30c9\u3092\u7d44\u307f\u5408\u308f\u305b\u308b\u7406\u7531","description":"\u30ea\u30ea\u30fc\u793e\u306f\u30012\u578b\u7cd6\u5c3f\u75c5\u306e367\u6210\u4eba\u3092\u5bfe\u8c61\u3068\u3057\u305f48\u9031\u9593\u306e\u7b2c2b\u76f8\u4f75\u7528\u8a66\u9a13\u3092\u5831\u544a\u3057\u307e\u3057\u305f\u3002\u4f53\u91cd\u306e\u7d50\u679c\u3001\u4e2d\u6b62\u4f8b\u3001\u88fd\u5264\u4e0a\u306e\u9650\u754c\u306b\u3064\u3044\u3066\u7406\u89e3\u3057\u307e\u3057\u3087\u3046\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/ja\/eloratzp-\u30a2\u30df\u30ea\u30f3-\u30c1\u30eb\u30bc\u30d1\u30c1\u30c9-\u30d5\u30a7\u30fc\u30ba2b-\u7d50\u679c\u306e\u89e3\u8aac\/","og_locale":"ja_JP","og_type":"article","og_title":"EloraTZP: Why Researchers Are Combining Amylin and Tirzepatide","og_description":"Lilly reported a 48-week phase 2b combination study in 367 adults with type 2 diabetes. Understand the weight results, discontinuations and formulation limits.","og_url":"https:\/\/nhdbio.com\/ja\/eloratzp-\u30a2\u30df\u30ea\u30f3-\u30c1\u30eb\u30bc\u30d1\u30c1\u30c9-\u30d5\u30a7\u30fc\u30ba2b-\u7d50\u679c\u306e\u89e3\u8aac\/","og_site_name":"NHD","article_published_time":"2026-10-09T14:46:46+00:00","article_modified_time":"2026-10-10T07:26:15+00:00","author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"\u57f7\u7b46\u8005":"NHD Technical Team","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/eloratzp-amylin-tirzepatide-phase2b-results-explained\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/eloratzp-amylin-tirzepatide-phase2b-results-explained\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"EloraTZP: Why Researchers Are Combining Amylin and Tirzepatide","datePublished":"2026-10-09T14:46:46+00:00","dateModified":"2026-10-10T07:26:15+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/eloratzp-amylin-tirzepatide-phase2b-results-explained\/"},"wordCount":625,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/eloratzp-amylin-tirzepatide-phase2b-results-explained\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/nhd-comic-3738.jpg","articleSection":["Published Study Reviews"],"inLanguage":"ja","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/eloratzp-amylin-tirzepatide-phase2b-results-explained\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/eloratzp-amylin-tirzepatide-phase2b-results-explained\/","url":"https:\/\/nhdbio.com\/eloratzp-amylin-tirzepatide-phase2b-results-explained\/","name":"EloraTZP\uff1a\u7814\u7a76\u8005\u304c\u30a2\u30df\u30ea\u30f3\u3068\u30c1\u30eb\u30bc\u30d1\u30c1\u30c9\u3092\u7d44\u307f\u5408\u308f\u305b\u308b\u7406\u7531","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/eloratzp-amylin-tirzepatide-phase2b-results-explained\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/eloratzp-amylin-tirzepatide-phase2b-results-explained\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/nhd-comic-3738.jpg","datePublished":"2026-10-09T14:46:46+00:00","dateModified":"2026-10-10T07:26:15+00:00","description":"\u30ea\u30ea\u30fc\u793e\u306f\u30012\u578b\u7cd6\u5c3f\u75c5\u306e367\u6210\u4eba\u3092\u5bfe\u8c61\u3068\u3057\u305f48\u9031\u9593\u306e\u7b2c2b\u76f8\u4f75\u7528\u8a66\u9a13\u3092\u5831\u544a\u3057\u307e\u3057\u305f\u3002\u4f53\u91cd\u306e\u7d50\u679c\u3001\u4e2d\u6b62\u4f8b\u3001\u88fd\u5264\u4e0a\u306e\u9650\u754c\u306b\u3064\u3044\u3066\u7406\u89e3\u3057\u307e\u3057\u3087\u3046\u3002","breadcrumb":{"@id":"https:\/\/nhdbio.com\/eloratzp-amylin-tirzepatide-phase2b-results-explained\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/eloratzp-amylin-tirzepatide-phase2b-results-explained\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nhdbio.com\/eloratzp-amylin-tirzepatide-phase2b-results-explained\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/nhd-comic-3738.jpg","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/nhd-comic-3738.jpg","width":1536,"height":1024,"caption":"Editorial comic illustration: Amylin Meets Tirzepatide. Conceptual cover, not experimental imagery."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/eloratzp-amylin-tirzepatide-phase2b-results-explained\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"EloraTZP: Why Researchers Are Combining Amylin and Tirzepatide"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"\u30da\u30d7\u30c1\u30c9\u539f\u6599\u30fb\u30ab\u30b9\u30bf\u30e0\u30da\u30d7\u30c1\u30c9\u5408\u6210","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"NHD\u6280\u8853\u30c1\u30fc\u30e0","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"NHD \u6280\u8853\u30c1\u30fc\u30e0\u306f\u3001\u7814\u7a76\u7528\u306e\u30ab\u30bf\u30ed\u30b0\u6587\u66f8\u3068\u8a3c\u62e0\u306e\u6982\u8981\u3092\u7ba1\u7406\u3057\u307e\u3059\u3002\u67fb\u8aad\u6e08\u307f\u306e\u8ad6\u6587\u306f\u3001\u67fb\u8aad\u6e08\u307f\u306e\u8ad6\u6587\u3001\u6cbb\u9a13\u767b\u9332\u304a\u3088\u3073\u898f\u5236\u8a18\u9332\u306b\u30ea\u30f3\u30af\u3057\u3066\u304a\u308a\u3001\u7121\u52b9\u306a\u6240\u898b\u3084\u7814\u7a76\u306e\u9650\u754c\u3092\u4fdd\u6301\u3057\u3001\u30ab\u30bf\u30ed\u30b0\u8cc7\u6599\u304b\u3089\u51fa\u7248\u3055\u308c\u305f\u4ecb\u5165\u3092\u533a\u5225\u3057\u307e\u3059\u3002 AI \u3092\u5229\u7528\u3057\u305f\u88fd\u56f3\u3092\u69cb\u9020\u306b\u4f7f\u7528\u3067\u304d\u307e\u3059\u3002\u30bd\u30fc\u30b9\u30ea\u30f3\u30af\u3068\u8a3c\u62e0\u306e\u5883\u754c\u306f\u8868\u793a\u3055\u308c\u305f\u307e\u307e\u306b\u306a\u308a\u307e\u3059\u3002\u3053\u306e\u7814\u7a76\u306f\u72ec\u7acb\u3057\u305f\u67fb\u8aad\u3084\u533b\u5b66\u7684\u30a2\u30c9\u30d0\u30a4\u30b9\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/ja\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/posts\/3738","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/comments?post=3738"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/posts\/3738\/revisions"}],"predecessor-version":[{"id":3742,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/posts\/3738\/revisions\/3742"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/media\/3923"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/media?parent=3738"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/categories?post=3738"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/tags?post=3738"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}